Pharming Group reports financial results for the first nine months of 2020
Pharming Group N.V. presents its (unaudited) financial report for the nine months and third quarter ended 30 September 2020.
- Continued solid performance and strong recovery of sales in Q3 2020
- Delivered 9.2% increase in revenues, 19.8% increase in operating profit and 6.4% increase in net profit (59% increase on constant currency basis) year-on-year for the first nine months of 2020
- Company has initiated the process for a secondary listing in the US on Nasdaq
We are pleased to announce continued growth during the first nine months of 2020, demonstrating consistent progress, despite the impact of the COVID-19 pandemic on sales and marketing activities and a significant decrease in the US dollar versus the Euro.- Sijmen de Vries - CEO